Serum ACE2 activity as a novel biomarker of assessment of severe aortic stenosis
Anita Kurczina(University of Debrecen), Attila Borbély, Ivetta Mányiné Siket(University of Debrecen), Zoltán Papp(University of Debrecen), Arnold Péter Ráduly(University of Debrecen), Ágnes Balogh(Bristol-Myers Squibb (Germany)), Zsófia Pólik(University of Debrecen), Tibor Fülöp(Medical University of South Carolina), Tamás Szerafin(Semmelweis University), Zoltán Csanádi(University of Debrecen), Attila Tóth(University of Debrecen), Bertalan Kracskó(University of Debrecen), Andrea Molnár(University of Debrecen), Miklós Fagyas(University of Debrecen), Csaba Ötvös(University of Debrecen), Attila Kertész(University of Szeged)
Cited by 0
Related Papers
Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
|European Journal of Heart Failure|2010|1.1k
Levosimendan: Molecular mechanisms and clinical implications
|International Journal of Cardiology|2011|313
The continuous heart failure spectrum: moving beyond an ejection fraction classification
|European Heart Journal|2019|258
Treatments targeting inotropy
|European Heart Journal|2018|227
A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider
|Patient Preference and Adherence|2022|156